FOIA Number: HHS-FDA-22-0116

FOIA to FDA for Communications Sent by FDA Drugs Advisory Committee Regarding Aduhelm

February 2, 2022
FOIA request to the U.S. Food and Drug Administration seeking communications sent by Peripheral and Central Nervous System Drugs Advisory Committee members regarding Aduhelm (aducanumab), an Alzheimer's drug produced by Biogen.